Stay updated with breaking news from Pipeline Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
08.08.2022 - - Collaboration with Astellas on discovery and development of iADCs for up to three targets, includes an upfront payment of $90 million and $422.5 million in potential milestones per product candidate - - A $10 million milestone payment from Merck ...
Actively enrolling participants in our Phase 2/3 clinical trial for the potential treatment of progressive NF2-mutated meningiomasOn track to init...
05.08.2022 - NEW YORK, Aug. 05, 2022 (GLOBE NEWSWIRE) - Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today reported recent company updates and financial ...
/PRNewswire/ -- Sutro Biopharma, Inc. ("Sutro" or the "Company") (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused...
Felt -- there was a level of connection with the lived experience that i -- it really connected with me. as a country, we need to do more. we have a lot of work to do but it starts with making sure that the students that we have in front of us that you said are so diverse see themselves as potential teachers in the future. and i have to say in the build back better agenda there is a plan to put funding there to make sure we're creating good pipeline programs so that the students that are in the classrooms now see themselves as the teachers leading the classrooms in the future. >> when it comes...